CD4 and systemic lupus erythematosus: In addition, rapamycin enhanced FoxP3 expression in CD25+/CD4+ T-cells and expansion of CD25+CD19+ B cells [73], signifying that mTOR can trigger IL-4 production by and necrosis of DN T cells in active SLE.